1. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999; 34:646–56.
2. Tejesh C, Shivanna S, Manjunath A, Prathima P. ICU management of methemoglobinemia due to unknown compound poisoning. J Anaesthesiol Clin Pharmacol. 2013; 29:139–40.
3. Curry S. Methemoglobinemia. Ann Emerg Med. 1982; 11:214–21.
4. Chegondi M, Shaked O. Methemoglobinemia in a neonate with diarrhea. Pediatr Oncall J. 2014; 11:88–9.
5. Elyassi AR, Rowshan HH. Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature. Anesth Prog. 2009; 56:86–91.
6. Darling RC, Roughton FJ. The effect of methemoglobin on the equilibrium between oxygen and hemoglobin. Am J Physiol Leg Content. 1942; 137:56–68.
7. Herzog P, Feig SA. Methaemoglobinaemia in the newborn infant. Clin Haematol. 1978; 7:75–83.
8. Manning JM, Manning LR, Dumoulin A, Padovan JC, Chait B. Embryonic and fetal human hemoglobins: structures, oxygen binding, and physiological roles. Subcell Biochem. 2020; 94:275–96.
9. Chandran S, Ross BJ, Kumar M. The journey from blue to pink–a rare cause for self-limiting methemoglobinemia in an Indian baby. Case Rep Perinat Med. 2022; 11:20210054.
10. Crowley MA, Mollan TL, Abdulmalik OY, Butler AD, Goodwin EF, Sarkar A, et al. A hemoglobin variant associated with neonatal cyanosis and anemia. N Engl J Med. 2011; 364:1837–43.
11. Bento C, Magalhaes Maia T, Carvalhais I, Moita F, Abreu G, Relvas L, et al. Transient neonatal cyanosis associated with a new Hb F variant: Hb F viseu. J Pediatr Hematol Oncol. 2013; 35:e77–80.
12. Alonso-Ojembarrena A, Lubian-Lopez SP. Hemoglobin M disease as a cause of cyanosis in a newborn. J Pediatr Hematol Oncol. 2016; 38:173–5.
13. Yuan J, Zhu XP. Clinical characteristics on manifestation and gene mutation of a transient neonatal cyanosis: a case report. World J Clin Cases. 2020; 8:217–21.
14. Senthilkumaran S, Balamurugan N, Ananth C, Thirumalaikolundusubramanian P. Methemoglobinemia and bedside diagnostic test: ready for prime time. J Postgrad Med. 2014; 60:213–4.
15. Hooven TA, Hooper EM, Wontakal SN, Francis RO, Sahni R, Lee MT. Diagnosis of a rare fetal haemoglobinopathy in the age of next-generation sequencing. BMJ Case Rep. 2016; 2016:bcr2016215193.
16. Ghotra S, Jangaard K, Pambrun C, Fernandez CV. Congenital methemoglobinaemia due to Hb F-M-Fort Ripley in a preterm newborn. BMJ Case Rep. 2016; 2016:bcr2016214381.
17. Spears F, Banerjee A. Hemoglobin M variant and congenital methemoglobinemia: methylene blue will not be effective in the presence of hemoglobin M. Can J Anaesth. 2008; 55:391–2.
18. Pushparajah Mak RS, Liebelt EL. Methylene blue: an antidote for methemoglobinemia and beyond. Pediatr Emerg Care. 2021; 37:474–7.
19. Gibson QH. The reduction of methaemoglobin by ascorbic acid. Biochem J. 1943; 37:615–8.
20. Jansen T, Barnung S, Mortensen CR, Jansen EC. Isobutyl-nitriteinduced methemoglobinemia: treatment with an exchange blood transfusion during hyperbaric oxygenation. Acta Anaesthesiol Scand. 2003; 47:1300–1.